Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

多西紫杉醇 医学 化疗 内科学 肺癌 肿瘤科 癌症 随机对照试验
作者
Frances A. Shepherd,Janet Ellen Dancey,Rodryg Ramlau,Karin V. Mattson,Richard J. Gralla,Mark Allen O’Rourke,Nathan I. Levitan,Laurent Gressot,Mark David Vincent,Ronald L. Burkes,Susan A. Coughlin,Yong Deok Kim,Jocelyne Bérille
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:18 (10): 2095-2103 被引量:2187
标识
DOI:10.1200/jco.2000.18.10.2095
摘要

PURPOSE: To evaluate whether treatment with single-agent docetaxel would result in longer survival than would best supportive care in patients with non-small-cell lung cancer who had previously been treated with platinum-based chemotherapy. Secondary end points included assessment of response (docetaxel arm only), toxicity, and quality of life. PATIENTS AND METHODS: Patients with performance statuses of 0 to 2 and stage IIIB/IV non-small-cell lung cancer with either measurable or evaluable lesions were eligible for entry onto the study if they had undergone one or more platinum-based chemotherapy regimens and if they had adequate hematology and biochemistry parameters. They were excluded if they had symptomatic brain metastases or if they had previously been treated with paclitaxel. Patients were stratified by performance status and best response to cisplatin chemotherapy and were then randomized to treatment with docetaxel 100 mg/m(2) (49 patients) or 75 mg/m(2) (55 patients) or best supportive care. Patients in both arms were assessed every 3 weeks. RESULTS: One hundred four patients (103 of whom were eligible for entry onto the study) were well balanced for prognostic factors. Of 84 patients with measurable lesions, six (7. 1%) achieved partial responses (three patients at each dose level). Time to progression was longer for docetaxel patients than for best supportive care patients (10.6 v 6.7 weeks, respectively; P <.001), as was median survival (7.0 v 4.6 months; log-rank test, P =.047). The difference was more significant for docetaxel 75 mg/m(2) patients, compared with corresponding best supportive care patients (7.5 v 4.6 months; log-rank test, P =.010; 1-year survival, 37% v 11%; chi(2) test, P =.003). Febrile neutropenia occurred in 11 patients treated with docetaxel 100 mg/m(2), three of whom died, and in one patient treated with docetaxel 75 mg/m(2). Grade 3 or 4 nonhematologic toxicity, with the exception of diarrhea, occurred at a similar rate in both the docetaxel and best supportive care groups. CONCLUSION: Treatment with docetaxel is associated with significant prolongation of survival, and at a dose of 75 mg/m(2), the benefits of docetaxel therapy outweigh the risks.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张颖涛发布了新的文献求助10
刚刚
小马甲的应助被竟文采纳,获得10
1秒前
sunny完成签到 ,获得积分10
2秒前
2秒前
lu7完成签到 ,获得积分10
3秒前
星野的应助被予诺采纳,获得10
4秒前
回锅肉完成签到 ,获得积分10
6秒前
胖球球完成签到,获得积分10
6秒前
Hsy驳回了Lucas的应助
6秒前
好名发布了新的文献求助10
7秒前
ZY发布了新的文献求助10
8秒前
9秒前
12秒前
张颖涛完成签到,获得积分10
12秒前
领导范儿的应助被灭建国采纳,获得10
12秒前
13秒前
隐形曼青的应助被FUTURE采纳,获得30
14秒前
orixero的应助被Joy采纳,获得10
14秒前
Jingxue_ZX的应助被武宁采纳,获得10
17秒前
17秒前
我是谁的应助被朴实归尘采纳,获得50
18秒前
桐桐的应助被孟宇采纳,获得10
18秒前
柚子完成签到,获得积分10
18秒前
领导范儿的应助被大将军采纳,获得10
19秒前
哈哈哈哈发布了新的文献求助10
20秒前
21秒前
21秒前
22秒前
weiqiliang完成签到,获得积分10
22秒前
jason完成签到,获得积分0
22秒前
栖梧砚客完成签到,获得积分10
24秒前
25秒前
折瑾完成签到,获得积分10
27秒前
科研通AI65的应助被开心德地采纳,获得10
27秒前
28秒前
科研通AI65的应助被瘦瘦大米采纳,获得10
28秒前
31秒前
31秒前
32秒前
修炼成绝完成签到,获得积分10
33秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188371
求助须知:如何正确求助?哪些是违规求助? 9576179
关于积分的说明 21845965
捐赠科研通 7786421
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559601
邀请新用户注册赠送积分活动 2482276